Skip to content

Protective Role of Some Dietary Supplements in Children with Bronchial Asthma

Protective Role of Some Dietary Supplements in Children with Bronchial Asthma

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
PACTR
Registry ID
PACTR202412555287430
Enrollment
150
Registered
2024-12-31
Start date
2021-04-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paediatrics

Interventions

vitamin C
Vitamin D
vitamin C and vitamin D and omega 3 PUFA
placebo

Sponsors

Faculty of medicine of Tanta university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Children having mild, moderate, and severe persistent asthma aged 6-18 years. ? As per the Global Initiative for Asthma guidelines, 2021, asthma diagnosis was based on the history of symptoms such as recurrent cough, wheezing, chest tightness, and shortness of breath, which either resolves spontaneously or with bronchodilators. The diagnosis was confirmed by demonstrating a significant improvement of 12% or more in the forced expiratory volume in one second (FEV1) after using short-acting bronchodilators in children aged >six years (GINA, 2021).

Exclusion criteria

Exclusion criteria: ? All children having the following conditions: - Clinical evidence of heart diseases, renal or hepatic insufficiency - Cystic fibrosis or congenital respiratory diseases - Chronic diarrhea or malabsorption - Clinical evidence of malnutrition ? Children who receiving any nutritional supplements in the last six months before the study and those who will be incompliant with the intervention. ? Children whose parents refused to participate in this study

Design outcomes

Primary

MeasureTime frame
? Assessing related side effects, if any, ?Determining the degree of asthma severity, ?Evaluating the asthma control test score, Conducting pulmonary function tests, and ?Measuring the serum levels of vitamins C and D, glutathione reductase, malondialdehyde, matrix metalloproteinase-9, and interleukin-17.

Secondary

MeasureTime frame
? Conducting pulmonary function tests, and ? Measuring the serum levels of vitamins C and D, glutathione reductase, malondialdehyde, matrix metalloproteinase-9, and interleukin-17.

Countries

Egypt

Contacts

Public ContactDoaa El sawy

lecturer of pediatrics

doaaelsawy99@gmail.com01023403551

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026